Literature DB >> 1649568

Enhancement of macrophage superoxide anion production by amphotericin B.

E Wilson1, L Thorson, D P Speert.   

Abstract

Amphotericin B (AmB) appears to have some important immunomodulatory effects, but its mechanism of action has not been explained. We investigated the effects of AmB on activation of human monocyte-derived macrophages. Macrophages cultured in the presence of AmB had an enhanced capacity to produce superoxide anion after stimulation with phorbol myristate acetate. This enhancement was dose dependent within a therapeutic range of AmB levels (0.1 to 3.0 mg/liter). Macrophages cultured in the presence of AmB had enhanced surface expression of Ia antigen; phagocytosis of unopsonized zymosan, opsonized Staphylococcus aureus, or erythrocytes opsonized with C3bi or immunoglobulin G paradoxically appeared to be reduced, but results did not achieve statistical significance. AmB appears to activate macrophages and may do so via direct effects on the plasma membrane.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1649568      PMCID: PMC245109          DOI: 10.1128/AAC.35.5.796

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  27 in total

1.  The extinction coefficient of cytochrome c.

Authors:  B van GELDER; E C SLATER
Journal:  Biochim Biophys Acta       Date:  1962-04-23

2.  Quantitative aspects of the production of superoxide radicals by phagocytizing human granulocytes.

Authors:  R S Weening; R Wever; D Roos
Journal:  J Lab Clin Med       Date:  1975-02

3.  Inhibition of human neutrophil chemotaxis and chemiluminescence by amphotericin B.

Authors:  B Björkstén; C Ray; P G Quie
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

4.  A new therapeutic approach to Candida infections. A preliminary report.

Authors:  G Medoff; W E Dismukes; R H Meade; J M Moses
Journal:  Arch Intern Med       Date:  1972-08

5.  Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent.

Authors:  B M Babior; R S Kipnes; J T Curnutte
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

6.  The effects of the polyene antibiotics nystatin and amphotericin B on thin lipid membranes.

Authors:  R W Holz
Journal:  Ann N Y Acad Sci       Date:  1974-05-10       Impact factor: 5.691

7.  Effects of antifungal agents and gamma interferon on macrophage cytotoxicity for fungi and tumor cells.

Authors:  J R Perfect; D L Granger; D T Durack
Journal:  J Infect Dis       Date:  1987-08       Impact factor: 5.226

8.  The polyene antibiotic amphotericin B inhibits the Na+/K+ pump of human erythrocytes.

Authors:  A Vertut-Doi; P Hannaert; J Bolard
Journal:  Biochem Biophys Res Commun       Date:  1988-12-15       Impact factor: 3.575

9.  Effects of amphotericin B on macrophages and their precursor cells.

Authors:  S H Lin; G Medoff; G S Kobayashi
Journal:  Antimicrob Agents Chemother       Date:  1977-01       Impact factor: 5.191

10.  Interferon-gamma depresses binding of ligand by C3b and C3bi receptors on cultured human monocytes, an effect reversed by fibronectin.

Authors:  S D Wright; P A Detmers; M T Jong; B C Meyer
Journal:  J Exp Med       Date:  1986-05-01       Impact factor: 14.307

View more
  19 in total

1.  Lipid complexing decreases amphotericin B inflammatory activation of human neutrophils compared with that of a desoxycholate-suspended preparation of amphotericin B (Fungizone).

Authors:  G W Sullivan; H T Carper; G L Mandell
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

Review 2.  Key issues concerning fungistatic versus fungicidal drugs.

Authors:  J R Graybill; D S Burgess; T C Hardin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-01       Impact factor: 3.267

3.  Reduction of no synthase expression and tumor necrosis factor alpha production in macrophages by amphotericin B lipid carriers.

Authors:  M Larabi; P Legrand; M Appel; S Gil; M Lepoivre; J Devissaguet; F Puisieux; G Barratt
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

4.  Effect of amphotericin B on capsule and cell size in Cryptococcus neoformans during murine infection.

Authors:  Oscar Zaragoza; Coralia Mihu; Arturo Casadevall; Joshua D Nosanchuk
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

Review 5.  Immunomodulating effects of antibiotics: literature review.

Authors:  B Van Vlem; R Vanholder; P De Paepe; D Vogelaers; S Ringoir
Journal:  Infection       Date:  1996 Jul-Aug       Impact factor: 3.553

6.  Effects of naftifine and terbinafine, two allylamine antifungal drugs, on selected functions of human polymorphonuclear leukocytes.

Authors:  T Vago; G Baldi; D Colombo; M Barbareschi; G Norbiato; F Dallegri; M Bevilacqua
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

7.  Novel aspect of amphotericin B action: accumulation in human monocytes potentiates killing of phagocytosed Candida albicans.

Authors:  E Martin; A Stüben; A Görz; U Weller; S Bhakdi
Journal:  Antimicrob Agents Chemother       Date:  1994-01       Impact factor: 5.191

Review 8.  Systemically administered antifungal agents. A review of their clinical pharmacology and therapeutic applications.

Authors:  C A Lyman; T J Walsh
Journal:  Drugs       Date:  1992-07       Impact factor: 9.546

9.  Effects of lipid formulations of amphotericin B on activity of human monocytes against Aspergillus fumigatus.

Authors:  J Dotis; M Simitsopoulou; M Dalakiouridou; T Konstantinou; A Taparkou; F Kanakoudi-Tsakalidou; T J Walsh; E Roilides
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

Review 10.  Optimizing efficacy of Amphotericin B through nanomodification.

Authors:  Gillian Barratt; Stéphane Bretagne
Journal:  Int J Nanomedicine       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.